switched from semaglutide to tirzepatide and gained weight Why You Might Tolerate One Loss Drug Better Than Another Tirzepatide vs. Semaglutide for Weight

Both formulations share the active ingredient, semaglutide, and operate through the GLP-1 receptor pathway, yet they differ in administration and absorption processes

Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Higher, clinically studied doses (500mg or more) tend to show results more reliably

Mental and Psychological Benefits : It can prevent the monotony of constant dietary restrictions, offering psychological relief on higher carb days, which can make it easier to adhere to over time 5

5,6 "These new films showcase our point of view around obesityemphasizing our commitment to patients by highlighting the seriousness of this disease and the appropriate use of anti-obesity medicines," said Jennifer Oleksiw, global chief customer officer, Eli Lilly, in a press release

The most commonly reported adverse effects are gastrointestinal in nature, including nausea, diarrhea, vomiting, constipation, and abdominal pain